Kinesia 360 Parkinson's Monitoring Study

Completed · Not applicable

Conditions studied: Parkinson's Disease

In brief

Kinesia 360 is an ambulatory symptom monitoring device for Parkinson's Disease (PD). The aim of this study is to investigate the impact, validation, and usability of the Kinesia 360 system.

Key facts

Study ID

NCT02657655

Run by

Great Lakes NeuroTechnologies Inc.

People needed

45

Starts

2016-01-01

Expected to finish

2017-02-01

Last updated by the study team

2018-02-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Idiopathic Parkinson's Disease,
• History of motor fluctuations (2 hrs/day of Off time and/or 1 hr/day of troublesome dyskinesia)
• Fluent in English

You may not qualify if…

• Inability to carry out study activities
• Subjects with cognitive deficits that would prevent following instructions and serious medical conditions that would compromise a subject's safety
• Subjects who have dementia, exhibited by Montreal Cognitive Assessment (MoCa) score of 22 or less.
• Subjects who have had Deep Brain Stimulation (DBS) surgery less than 6 months prior to study enrollment, or who are deemed by the study investigator to be highly likely to undergo DBS surgery during the 6 month study period.

Where it is running

• Johns Hopkins University — Baltimore, Maryland, United States
• University of Rochester — Rochester, New York, United States
• Cleveland Clinic — Cleveland, Ohio, United States
• Greenville Health System — Greenville, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.